Stock Market Reviews and Analysis: Sartorius Stedim Biotech, BNP Paribas, Renault, and Eurofins Scientific

2023-12-20 08:00:00

Published on Dec 20 2023 at 9:00 Updated Dec 20 2023 at 9:21

Sartorius Stedim Biotech : following Alpha Value/Baader on Tuesday, Barclays reviews its target price on the biotech industry equipment manufacturer. It is increased from 185 to 210 euros, with a recommendation maintained at “online weighting”.

Alpha Value/Baader had for its part downgraded the title from “buy” to “accumulate” with a target of 282 euros.

RBC, for its part, reviews the French banking sector. The broker remains more favorable to BNP Paribaswith an outperformance recommendation, for a price target raised from 75 to 82 euros.

The intermediary is, on the contrary, “performing in line with the sector” on Agricultural credit et Societe Generalethe target price having increased from 13.50 to 15.50 euros for the first and from 29 to 30.50 euros for the second.

Renault : Stifel, when purchasing, aims for 2 euros more, or 53 euros.

Eurofins Scientific : Exane BNP Paribas, at “underperformance”, slightly raises its price target, from 48.50 to 50 euros.

Which stocks to buy?

Making the best investments requires detailed knowledge of the markets, their mechanisms, the economy and involves delving into the heart of the strategy of each listed company. The Investir editorial team does it for you and provides its subscribers with advice on more than 800 stocks. Benefit from their buy, speculative buy, spread or sell recommendations by subscribing to Investir.

I discover the offers
1703069290
#BNP #Paribas #Crédit #Agricole #Société #Générale #Renault #Eurofins #Scientific #Sartorius #Stedim #analysts #recommendations

Leave a Replay